Is Macro Bank (BMA) Stock Outpacing Its Finance Peers This Year?

BMA

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Is Macro Bank (BMA - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.

Macro Bank is one of 854 companies in the Finance group. The Finance group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. BMA is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for BMA's full-year earnings has moved 14.19% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, BMA has moved about 23.52% on a year-to-date basis. At the same time, Finance stocks have gained an average of 11.15%. As we can see, Macro Bank is performing better than its sector in the calendar year.

Breaking things down more, BMA is a member of the Banks - Foreign industry, which includes 64 individual companies and currently sits at #211 in the Zacks Industry Rank. On average, stocks in this group have gained 7.18% this year, meaning that BMA is performing better in terms of year-to-date returns.

Investors with an interest in Finance stocks should continue to track BMA. The stock will be looking to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>